Skip to main content
. 2014 May 1;8(5):e2837. doi: 10.1371/journal.pntd.0002837

Table 1. Validation the interaction between the mutants and the SjScrib-PDZ domains by Y2H assays.

SjScrib-PDZ4 Ligand sequence and point mutation1 Y2H2
P1-L8M CMES(A)HFY* ×
P1-L10M SLQET(A)DIE* ×
P1-L23M FHSYRYTET(A)HIK* ×
P1-L34M YPHSEAMET(A)SIE* ×
P1-L35M SFTEET(A)FIE* ×
P1-L44M LFLTVTNMVAEKPAES(A)EIN* ×
P1-L1M SDNHFLHNVTSGCDLIWDET(A)EIDLE* ×
P1-L22M CDEKYMVVARET(A)NIEMGFPEEASLKK* ×
P1-L25M LNIRPKTIKTLEENLGITIQDIGMGKDFMSKTPKAMATKDKIFFKDPTKGFLQET(A)HFPGNNTNRK* ×
SjScrib-PDZ2
P2-L1M1 SNNVNKMKMVLTKKVTEEEVSINRGLLTPKFEDVPRKNTVTEASVTYAFQRGFWELSI(T)* ×
P2-L1M2 SNNVNKMKMVLTKKVTEEEVSINRGLLTPKFEDVPRKNTVTEASVTYAFQRGFWELS(A)I* ×
P2-L1M3 SNNVNKMKMVLTKKVTEEEVSINRGLLTPKFEDVPRKNTVTEASVTYAFQRGFWEL(T)SI* ×
P2-L1M4 SNNVNKMKMVLTKKVTEEEVSINRGLLTPKFEDVPRKNTVTEASVTYAFQRGFWE(A)LSI* ×
P2-L1M5 SNNVNKMKMVLTKKVTEEEVSINRGLLTPKFEDVPRKNTVTEASVTYAFQRGFW(T)ELSI* ×
P2-L1M6 SNNVNKMKMVLTKKVTEEEVSINRGLLTPKFEDVPRKNTVTEASVTYAFQRGF(T)WELSI*
P2-L2M1 CLVTDELWTWTFELML*
P2-L2M2 CLVTDELWTWTFELML(T)E* ×
P2-L2M3 CLVTDELWTWTFELM(T)LE* ×
P2-L2M4 CLVTDELWTWTFEL(T)MLE* ×
P2-L2M5 CLVTDELWTWTFE(A)LMLE* ×
P2-L2M6 CLVTDELWTWTF(T)ELMLE* ×
SjScrib-PDZ3
P3-L2M SRKKYIKRWAKDMNRHLSKENIHMPTIRKET(A)FLE* ×
P3-L59M FHFYPISRET(A)WFL* ×
P3-L3M SFQSSKCRVIFKETNIKAEVTT(A)VCVYVCLMSEKEPIDSKRPEFPSLIPPGWASIRDPSSSSCR* ×
P3-L34M GNYT(A)SIIFFPGKKENPKVTR* ×
P3-L35M SSAAGTKHNVST(A)IIFFHPPKQM* ×
P3-L41M NFTT(A)VILLHCQHPDQETEHH* ×
P3-L50M SPGFCLRPSRKCPCGSSKTT(A)VLLWLGNP* ×
P3-L51M SSTLNLVKPHFFET(A)WIFW* ×
P3-L56M WLNSPRLSIGPFTMQNITT(A)VIYFRGFTNSNSVKFSCLSLLSSWDYRHAPPQQANSQA* ×
P3-L70M LRQPEHYWAWGLSPYEYLECLPKDRQKKAQTVRTT(A)IILFHPIHKPS* ×
P3-L79M NFKVFSPLDREKVWFST(A)CILFRRSSEYESSAVNEKIPKLNSTRVGIDTGSIELELQMNRRY* ×
P3-L104M FIRET(A)WVQKSKAVSYISFLIST* ×
P3-L117M NSST(A)FIYLFIFA* ×
P3-L134M FPLKHFTVLHTQST(A)CVLFLLSSHKRT* ×
SjScrib-PDZ4
P4-L4M1 LRKITRPHAINNHRPEKEKTYFQYKKELVKSGRGWESSGWQLCA(T)DCLSLIYL* ×
P4-L4M2 LRKITRPHAINNHRPEKEKTYFQYKKELVKSGRGWESSGWQL(T)CADCLSLIYL* ×
P4-L4M3 LRKITRPHAINNHRPEKEKTYFQYKKELVKSGRGWESSGW(T)QLCADCLSLIYL* ×
P4-L32M1 ASALIRYGRKILNSCWCLFRSSFLPGSHECRGVDIHKLWEGKVRNARFYLARPSFVTTFPCGASW(T)* ×
P4-L32M2 ASALIRYGRKILNSCWCLFRSSFLPGSHECRGVDIHKLWEGKVRNARFYLARPSFVTTFPCGA(T)SW* ×
P4-L32M3 ASALIRYGRKILNSCWCLFRSSFLPGSHECRGVDIHKLWEGKVRNARFYLARPSFVTTF(T)PCGASW* ×
P4-L39M1 YSPLPLMARRYKSYLPSGF(T)* ×
P4-L39M2 YSPLPLMARRYKSYLPS(R)GF* ×
P4-L39M3 YSPLPLMARRYKSY(T)LPSGF* ×
P4-L8M1 SIIFSLET(R)* ×
P4-L8M2 SIIFSL(T)ET* ×
P4-L8M3 SIIF(T)SLET* ×
P4-L42M1 CFIMCFVIRKRNGVSFVIAT(R)* ×
P4-L42M2 CFIMCFVIRKRNGVSFVI(T)AT* ×
P4-L42M3 CFIMCFVIRKRNGVSF(T)VIAT* ×
1

: The potential PBMs within the irregular ligands of each PDZ domain of SjScrib are shown in bold and underline. The substituted residues are indicated in brackets.

2

: √: positive in the Y2H system; ×: negative in the Y2H system.